Liqiang Zhou

2.2k total citations
86 papers, 1.6k citations indexed

About

Liqiang Zhou is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Liqiang Zhou has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 41 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Liqiang Zhou's work include Lymphoma Diagnosis and Treatment (44 papers), Viral-associated cancers and disorders (26 papers) and Cancer-related molecular mechanisms research (11 papers). Liqiang Zhou is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Viral-associated cancers and disorders (26 papers) and Cancer-related molecular mechanisms research (11 papers). Liqiang Zhou collaborates with scholars based in China, United States and Switzerland. Liqiang Zhou's co-authors include Ye‐Xiong Li, Yi‐Wu Yuan, Shulian Wang, Weihu Wang, Xiaohui He, Xin-Fan Liu, Jing Jin, Yue‐Ping Liu, Chuan Liu and You Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Liqiang Zhou

83 papers receiving 1.6k citations

Peers

Liqiang Zhou
Hyun Jung Jun South Korea
Yue Lu China
Theresa Scognamiglio United States
Michael D. Axelson United States
Liqiang Zhou
Citations per year, relative to Liqiang Zhou Liqiang Zhou (= 1×) peers Weili Zhao

Countries citing papers authored by Liqiang Zhou

Since Specialization
Citations

This map shows the geographic impact of Liqiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiang Zhou more than expected).

Fields of papers citing papers by Liqiang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiang Zhou. The network helps show where Liqiang Zhou may publish in the future.

Co-authorship network of co-authors of Liqiang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Liqiang Zhou. A scholar is included among the top collaborators of Liqiang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqiang Zhou. Liqiang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dongyang, et al.. (2024). Research on Natural Gas Leakage and Explosion Mechanisms in a Container House. Buildings. 14(12). 3752–3752. 3 indexed citations
2.
Zhang, Hui, et al.. (2023). Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1‐mediated glycolysis reprogramming. The Kaohsiung Journal of Medical Sciences. 39(9). 904–915. 2 indexed citations
3.
Liu, Fei, et al.. (2023). Study on the Propagation Law of Explosion Shock Waves in Closed Variable-Section Tube Under High-Pressure Environment. Journal of Vibration Engineering & Technologies. 12(6). 7249–7264. 5 indexed citations
4.
Yang, Guangjian, Yi Cai, Junling Li, et al.. (2022). Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China. Frontiers in Pharmacology. 13. 919652–919652. 8 indexed citations
5.
Shi, Yuankai, Haizhu Chen, Yan Qin, et al.. (2022). Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018). SHILAP Revista de lepidopterología. 1(1). 3–11. 4 indexed citations
6.
Zhou, Liqiang, et al.. (2021). Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets. Cancer Medicine. 10(10). 3309–3322. 15 indexed citations
7.
Zhou, Liqiang, Hao Lü, Fei Zeng, et al.. (2021). Constructing a new prognostic signature of gastric cancer based on multiple data sets. Bioengineered. 12(1). 2820–2835. 21 indexed citations
8.
Lin, Xin, Hao Lu, Chuan Liu, et al.. (2021). Methionine deficiency promoted mitophagy via lncRNA PVT1-mediated promoter demethylation of BNIP3 in gastric cancer. The International Journal of Biochemistry & Cell Biology. 141. 106100–106100. 23 indexed citations
9.
Zhou, Liqiang, Qi Zhou, You Wu, & Xin Lin. (2021). Integrating 13 Microarrays to Construct a 6 RNA-binding proteins Prognostic Signature for Gastric Cancer patients. Journal of Cancer. 12(16). 4971–4984.
10.
Lin, Xin, You Wu, Chuan Liu, et al.. (2021). Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer. Molecular Immunology. 140. 196–205. 68 indexed citations
11.
Jiang, Shiyu, Yan Qin, Peng Liu, et al.. (2020). Prognostic Nomogram and Predictive Factors in Refractory or Relapsed Diffuse Large B-Cell Lymphoma Patients Failing Front-Line R-CHOP Regimens. Journal of Cancer. 11(6). 1516–1524. 6 indexed citations
12.
Chen, Haizhu, Yan Qin, Jianliang Yang, et al.. (2020). Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma. Annals of Hematology. 99(12). 2847–2857. 3 indexed citations
13.
Shi, Yuankai, Ying Han, Jianliang Yang, et al.. (2019). Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China. Chinese Journal of Cancer Research. 31(1). 152–161. 62 indexed citations
14.
Lin, Xin, et al.. (2018). METase promotes cell autophagy via promoting SNHG5 and suppressing miR-20a in gastric cancer. International Journal of Biological Macromolecules. 122. 1046–1052. 26 indexed citations
15.
Chen, Juan, Jiarui Yuan, Liqiang Zhou, et al.. (2017). Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway. Biomedicine & Pharmacotherapy. 87. 118–126. 40 indexed citations
16.
Tao, Yunxia, et al.. (2015). [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].. PubMed. 37(6). 466–71. 1 indexed citations
17.
Zhang, Ximei, Ye‐Xiong Li, Weihu Wang, et al.. (2012). Survival Advantage With the Addition of Radiation Therapy to Chemotherapy in Early Stage Peripheral T-Cell Lymphoma, Not Otherwise Specified. International Journal of Radiation Oncology*Biology*Physics. 85(4). 1051–1056. 14 indexed citations
19.
Zhou, Liqiang. (2003). Age-dependent increase of NF-κB translocation and PDGF-B expression in aortic endothelial cells of hypercholesterolemic rats. Experimental Gerontology. 38(10). 1161–1168. 9 indexed citations
20.
Li, Ye‐Xiong, et al.. (1998). Primary non-hodgkin's lymphoma of the nasal cavity. Cancer. 83(3). 449–456. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026